Cargando…

Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension

Cardiac magnetic resonance (CMR) measures of right ventricular (RV) mass, volumes, and function have diagnostic and prognostic value in pulmonary arterial hypertension (PAH). We hypothesized that RV mass‐based metrics would discriminate incident PAH as redefined by the lower mean pulmonary arterial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simpson, Catherine E., Kolb, Todd M., Hsu, Steven, Zimmerman, Stefan L., Corona‐Villalobos, Celia P., Mathai, Stephen C., Damico, Rachel L., Hassoun, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052971/ https://www.ncbi.nlm.nih.gov/pubmed/35506079 http://dx.doi.org/10.1002/pul2.12005

Ejemplares similares

Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension
por: Hsu, Steven, et al.
Publicado: (2020)

Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

A novel approach to perioperative risk assessment for patients with pulmonary hypertension
por: Hassan, Hussein J., et al.
Publicado: (2021)

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Quantifying 4D flow cardiovascular magnetic resonance vortices in patients with pulmonary hypertension: A pilot study
por: Borhani, Ali, et al.
Publicado: (2023)

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
por: Mercurio, Valentina, et al.
Publicado: (2022)

Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
por: Naranjo, Mario, et al.
Publicado: (2022)

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction
por: Bourji, Khalil I., et al.
Publicado: (2017)

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study
por: Sato, Takahiro, et al.
Publicado: (2017)

A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension
por: Farrell, Christine, et al.
Publicado: (2022)

Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

Focused Review of Perioperative Care of Patients with Pulmonary Hypertension and Proposal of a Perioperative Pathway
por: Steppan, Jochen, et al.
Publicado: (2018)

Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact
por: Mercurio, Valentina, et al.
Publicado: (2018)

Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans
por: Blanco, Isabel, et al.
Publicado: (2014)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

The importance of the World Symposium on Pulmonary Hypertension
por: Jardim, Carlos, et al.
Publicado: (2018)

Pulmonary Hypertension and Indicators of Right Ventricular Function
por: von Siebenthal, Célia, et al.
Publicado: (2016)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

PDE9A deficiency does not prevent chronic‐hypoxic pulmonary hypertension in mice
por: Kolb, Todd M., et al.
Publicado: (2021)

Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
por: Bonner, Nicola, et al.
Publicado: (2013)

Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival
por: Yang, Jun, et al.
Publicado: (2020)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
por: De Bakker, Chantal C., et al.
Publicado: (2020)

Use of thermodilution cardiac output overestimates diagnoses of exercise-induced pulmonary hypertension
por: Hsu, Steven, et al.
Publicado: (2017)

Beyond the World Symposium on Pulmonary Hypertension: practical management of pulmonary arterial hypertension and evolving concepts
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Lessons from lung transplantation: Cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease
por: Goobie, Gillian C., et al.
Publicado: (2019)

Left atrial ablation for the management of atrial tachyarrhythmias in patients with pulmonary hypertension: A case series
por: Boyle, Thomas A., et al.
Publicado: (2022)

Reappraisal of the Transthoracic Echocardiographic Algorithm in Predicting Pulmonary Hypertension Redefined by Updated Pulmonary Artery Mean Pressure Threshold
por: Tanyeri, Seda, et al.
Publicado: (2023)

Regional longitudinal bi-ventricular function in pulmonary hypertension: single heart-beat assessment of strain by fast-senc imaging
por: Shehata, Monda L, et al.
Publicado: (2011)

Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Right ventricular assessment in pulmonary hypertension
por: Labrada, Lyana, et al.
Publicado: (2023)

Coronary flow reserve correlates with right ventricular dysfunction and predicts right heart failure in patients with pulmonary arterial hypertension
por: Skrok, Jan, et al.
Publicado: (2011)

An overview of the 6th World Symposium on Pulmonary Hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load
por: Metkus, Thomas S., et al.
Publicado: (2016)

Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact
por: Naranjo, Mario, et al.
Publicado: (2021)

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
por: Chang, Kevin Y., et al.
Publicado: (2022)

Phenotyping pulmonary hypertension in systemic sclerosis: a moving target
por: Mercurio, Valentina, et al.
Publicado: (2018)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
por: Tuhy, Tijana, et al.
Publicado: (2023)

Left ventricular heart failure and pulmonary hypertension(†)
por: Rosenkranz, Stephan, et al.
Publicado: (2016)

Severe pulmonary hypertension and right ventricular failure
por: Kumar, Ajay, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3k3dnhkt2cga4lmops56j6tcmo